期刊文献+

结直肠癌肝转移同期切除适应证及并发症防治 被引量:2

Indication of synchronous resection of colorectal liver metastases and management of its complications
原文传递
导出
摘要 结直肠癌肝转移手术策略的选择是结直肠癌治疗的热点和难点之一。同期肝切除手术因其具有避免多次手术打击、不会中断连续的系统化疗等优点,受到越来越多学者的青睐。对于一般状况较好,原发灶可切除,肝转移灶小且多位于周边或局限于半肝,肝切除范围较小时,肝外转移可切除的病人,可考虑同期肝切除手术。认真进行术前评估,严格筛选合适病例,提高手术操作水平并加强围术期管理有助于减少并发症的发生,改善病人预后。 The surgical strategy of colorectal liver metastases is one of the most controversy issues of the treatment of colorectal cancer. Synchronous hepatectomy is favored by more and more surgeons due to its advantages of avoiding repeated surgical strike, not interrupting the continuity of system chemotherapy. Synchronous hepatectomy is recommended for patients whose general condition is good, primary cancer is resectable, hepatic metastases are small, and locate in the periphery of liver or are confined to the hemiliver, liver resection volume is small, and extrahepatic metastases are resectable. Careful preoperative assessment, strict screening for suitable cases, enhancing the surgical techniques and strengthening the perioperative management are conductive to reducing complications and improving patients' prognosis.
出处 《中国实用外科杂志》 CSCD 北大核心 2013年第8期653-656,共4页 Chinese Journal of Practical Surgery
关键词 结直肠癌 肝转移 同期切除 适应证 并发症 colorectal cancer liver metastasis synchronoushepatectomy indication complication
  • 相关文献

参考文献16

  • 1Rees M, Tekkis PP, Welsh FK, et al. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients [J]. Ann Surg,2008,247(1): 125-135.
  • 2Adam R. Colorectal cancer with synchronous liver metastases [J]. Br J Surg, 2007, 94(2):129-131.
  • 3Alberts SR, Wagman LD.Chemotherapy for colorectal cancer liv- er metastases [ J ]. Oncologist ,2008,13 ( 10): 1063 - 1073.
  • 4Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer[J]. N Engl J Med, 2004,350(23):2335-2342.
  • 5Shanna S, Camci C, Jabbour N.Management of hepatic metasta- sis from colorectal cancers: an update [J]. J Hepatobiliary Pan- creat Surg,2008,15(6):570-580.
  • 6Fahy BN, D'Angelica M, DeMatteo RP, et al. Synchronous hepat- ic metastases from colon cancer: changing treatment strategies and results of surgical intervention [J ]. Ann Surg Oncol,2009,16 (2):361-370.
  • 7Timmerman RD, Bizekis CS, Pass HI, et al.Local surgical, abla- tive, and radiation treatment of metastases [ J ]. CA Cancer J Clin, 2009,59(3): 145-170.
  • 8Mehta NN, Ravikumar R, Coldham CA,et al.Effect of preopera- tive chemotherapy on liver resection for colorectal liver metasta- ses[J]. Eur J Surg Oncol,2008,34(7):782-786.
  • 9Klinger M, Eipeldauer S, Hacker S, et al. Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases [J ]. Eur J Surg Oncol,2009,35 (5): 515-520.
  • 10Azoulay D, Castaing D, Small A, et al. Resection of nonresect-able liver metastases from colorectal cancer after percutaneous portal vein embolization[J]. Ann Surg, 2000, 231(4):480-486.

同被引文献22

  • 1Pathak S,Sarno G,Nunes QM. Synchronous resection for colorectal liver metastases:the future[J].EUROPEAN JOURNAL OF SURGICAL ONCOLOGY,2010,(11):1044-1046.
  • 2Mentha G,Majno PE,Andres A. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary[J].British Journal of Surgery,2006,(07):872-878.
  • 3Benzoni E,Cojutti A,Lorenzin D. Liver resective surgery:a multivariate analysis of postoperative outcome and complication[J].Langenbecks Archives of Surgery,2007,(01):45-54.
  • 4Wolf PS,Park JO,Bao F. Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer:a single institution experience[J].Journal of the American College of Surgeons,2013,(01):41-49.
  • 5Nakajima K,Takahashi S,Saito N. Efficacy of the predicted operation time (POT) strategy for synchronous colorectal liver metastasis (SCLM):feasibility study for staged resection in patients with a long POT[J].Journal of Gastrointestinal Surgery,2013,(04):688-695.
  • 6Farid SG,Aldouri A,Morris-Stiff G. Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis[J].ANNALS OF SURGERY,2010,(01):91-100.
  • 7Katz SC,Shia J,Liau KH. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma[J].ANNALS OF SURGERY,2009,(04):617-623.
  • 8Feng Q, Wei Y, Zhu D, et al. Timing of hepatectomy for resectabte synchronous eolorectal liver metastases: for whom simuhaneous resection is more suitable--a meta-analysis[J]. PLoS One, 2014,9(8): 1043-I048.
  • 9She WH, Chan AC, Poon RT,et al. Defining an optimal surgical strategy for synchronous colorectal liver metastases: staged versus simultaneous resection[J]. ANZ J Surg,2014,10(12) : 919-923.
  • 10Silberhumer GR, Paty PB, Temple LK,et al. Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure[l]. Am J Surg, 2014,12( 13):293-297.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部